Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

RPS proclaims 'solid' financial results despite fall in profits

The society turned a profit for the second year in a row despite predicting losses of more than £200,000, its AGM has revealed

The Royal Pharmaceutical Society (RPS) is in a "very solid" financial position following its second consecutive year of profits, its finance director has claimed.


After reporting losses in 2010 and 2011, the RPS had exceeded expectations to make net profits of £227,000 in 2012 and £47,000 last year, RPS director of finance Simon Redman told members at the organisation's annual general meeting on Monday (June 23).


RPS staff had "reluctantly accepted" the need for costs to be controlled, and this had ensured the society's balance sheet remained "very robust" in 2013, he said.


The society turned a profit for the second year in a row despite predicting losses of more than £200,000, its AGM has revealed

More on the Royal Pharmaceutical Society

RPS charter sets out standards of patient care

Pharmacists must improve medicines adherence, says RPS report

Results of e-cigarette survey fail to sway RPS

The society suffered losses of £309,000 in 2010 and £1.1 million in 2011. After turning a profit in 2012, it had predicted losses of £230,000 in 2013, Mr Redman told the meeting.


The acquisition of its new headquarters in London's Smithfield last year generated £7m in net assets for the RPS, bringing its total assets close to £15m, Mr Redman said. This figure should increase further once the full benefits of the sale of its current headquarters in Lambeth are felt next year, he said.


Last year had marked the start of a programme of investment by the RPS in its faculty scheme and the redesign of its Pharmaceutical Press publications, Mr Redman said. This investment, which was designed to stop the "erosion" of salaries and create income opportunities, was now starting to "bear fruit", he added.


The RPS announced its intention to sell its Lambeth headquarters in 2012, as part of its ongoing effort to "improve efficiency and cost-effectiveness".


Last year, Mr Redman told members that work to refurbish the new headquarters was continuing "at a pace" to make it ready for the move in late 2014 or early 2015. He predicted that annual overheads would be £400,000 lower than they are in Lambeth.


How else could the RPS improve efficiency and cost-effectiveness?
 
We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD017091

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel